AVA Biochem Adds FDCA to Boost Bio-plastics

Swiss biochemical company AVA Biochem is adding furan derivative 2,5-furandicarboxylic acid (FDCA) to its product portfolio in order to support the development of bio-based plastics.

At its plant in Muttenz, Switzerland, the company is now producing FDCA from the oxidation of 5 (hydroxymethyl)furfural (5-HMF). The plant, which started operations in February 2014, produces 5-HMF from renewable feedstocks using AVA Biochem’s proprietary hydrothermal processing technology.

FDCA produced from 5-HMF can be used to make bio-based polyethylene furanoate (PEF) and other bio-plastics. AVA Biochem said these materials have a variety of sought-after advantages which will help bio-based plastics boost their share of the billion-dollar packaging market.

The company said producing FCDA from 5-HMF on an industrial scale yielded significant cost advantages, paving the way for competitively priced bio-based packaging in the future.

AVA Biochem’s chief marketing officer Thomas Kläusli said the addition of FDCA was an important milestone for the company. “This will significantly accelerate market development of 100% bio-based plastic packaging based on PEF, a renewable replacement material for polyethylene terephthalate (PET),” he said.

The company will now supply FDCA to companies engaged in the research and development of new products.

According to AVA Biochem, furan derivatives produced from renewable carbohydrates are some of the most important next-generation platform chemicals. In 2004, the US Department of Energy classed FDCA as one of the 12 most important platform chemicals globally.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.